Table 3:
Prognostic Classification Systems for MDS/MPN
| Blasts | Cyto | Hgb | Plts | Circulating IMC | ANC | ALC | LDH | Age | Transfusion Dependency | PS | ASXL-1 mut | Cytogenetics | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| IPSS(1997) | + | + | + | + | + | + | |||||||
| WPSS | + | + | + | + | |||||||||
| MDA-LR | + | + | + | + | + | ||||||||
| MDAPS (2002) | + | + | + | + | |||||||||
| MDAPS-M1 (2007) | + | + | + | + | |||||||||
| MDAS (2008) | + | + | + | + | + | + | + | + | |||||
| FPSS | + | + | + | + | |||||||||
| IPSS-R (2012) | + | + | + | + | + | + | + | + | |||||
| CPSS (2013) | + | + | + | + | + | ||||||||
| Molecular Mayo Model (2014) | + | + | + | + | |||||||||
| CPSS-mol (2016) | + | + | + |
IPSS: International Prognostic Scoring System
WPSS: WHO Classification-Based Prognostic Scoring System
MDA-LR: M.D. Anderson Lower-Risk MDS Prognostic Scoring System
MDAPS: M.D. Anderson Prognostic Scoring System
MDAPS-M1: Modified M.D. Anderson Prognostic Scoring System
MDAS: Global MD Anderson Risk Model Score for MDS
FPSS: French Prognostic Scoring System
IPSS-R: Revised International Prognostic Scoring System
CPSS: Chronic Myelomonocytic Leukemia (CMML) Prognostic Scoring System
CPSS-mol: CMML-specific Prognostic Scoring System Molecular